Biofrontera AG (XETRA:B8F)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - B8F

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - B8F

  • Market Cap€139.030m
  • SymbolXETRA:B8F
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINDE0006046113

Company Profile

Biofrontera AG is active in the field of healthcare in the United Kingdom. It manufactures pharmaceutical products, especially medical cosmetics and dermatological drugs for the care and treatment of skin diseases. Its suite of products includes the prescription drugs Ameluz and BF-RhodoLED, for the treatment of actinic keratosis and Belixos, for the regenerative care of reddened and inflamed skin.Biofrontera AG is a pharmaceutical company in the United Kingdom. It develops drugs and cosmetic products for the treatment of skin related diseases.

Latest B8F news

Currently there for this company. Visit our news hub for other news .